Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Boehringer Ingelheim Venture Fundboehringer-ingelheim-venture.com · Low evidenceBoehringer Ingelheim Venture Fund invests in pioneering science to develop first-in-class, disease-modifying therapeutics across multiple modalities. The fund has invested in 70 companies and fund-in-fund opportunities globally, leveraging its team's deep pharmaceutical R&D expertise.
Parse Score